Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib

Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib

Tong Lin,1,2 Lan Gong1,2 1Department of Ophthalmology, Eye and ENT Hospital, Fudan University, 2Key Laboratory of Myopia, Ministry of Health, Shanghai, People’s Republic of China Purpose: To investigate the feasibility of nintedanib, a novel triple angiokinase inhibitor, for inhibiting l...

Full description

Bibliographic Details
Main Authors: Lin T, Gong L
Format: Article
Language:English
Published: Dove Medical Press 2017-04-01
Series:Drug Design, Development and Therapy
Subjects:
Kinase inhibitor
Lymphangiogenesis
In vitro
in vivo
Online Access:https://www.dovepress.com/inhibition-of-lymphangiogenesis-in-vitro-and-in-vivo-by-the-multikinas-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/inhibition-of-lymphangiogenesis-in-vitro-and-in-vivo-by-the-multikinas-peer-reviewed-article-DDDT

Similar Items